Al-Dawaa Medical Services Company
4163.SRSAUHealthcare● Active
$43.82
+$0.26(+0.60%)
Market Cap$3.7B
P/E Ratio—
52W High$80.05
52W Low$43
Al-Dawaa Medical Services Company (4163.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4163.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.32B | $0.37B | $0.33B | $0.32B | $0.25B |
| Depreciation & Amort. | $0.42B | $0.38B | $0.36B | $0.35B | $0.33B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.19B) | ($0.09B) | ($0.01B) | $0.15B | $0.15B |
| Net Cash from Operations | $0.66B | $0.68B | $0.73B | $0.78B | $0.67B |
| Investing Activities | |||||
| Capital Expenditure | ($0.15B) | ($0.23B) | ($0.22B) | ($0.29B) | ($0.32B) |
| Purchases of Investments | ($0.01B) | $0.00B | $0.00B | $0.00B | ($0.08B) |
| Sales of Investments | $0.00B | $0.13B | $0.05B | $0.00B | $0.02B |
| Net Cash from Investing | ($0.16B) | ($0.10B) | ($0.17B) | ($0.28B) | ($0.38B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.21B) | ($0.21B) | ($0.21B) | ($0.11B) | ($0.35B) |
| Debt Issued / Repaid | ($0.04B) | ($0.18B) | ($0.25B) | ($0.04B) | ($0.20B) |
| Net Cash from Financing | ($0.47B) | ($0.59B) | ($0.64B) | ($0.35B) | ($0.30B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.51B | $0.45B | $0.50B | $0.49B | $0.35B |
| FCF Margin %(computed) | 7.60% | 7.05% | 8.75% | 9.14% | 6.95% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Al-Dawaa Medical Services Company data
About Al-Dawaa Medical Services Company (4163.SR) Cash Flow Statement
Al-Dawaa Medical Services Company generated operating cash flow of $0.66B and free cash flow of $0.51B for 2025 — a FCF margin of 7.60%. Capital expenditure was ($0.15B).
Frequently asked questions
4163.SR · 4 questionsAl-Dawaa Medical Services Company generated free cash flow of $0.51B for 2025, up 12.7% year-over-year.
4163.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15